Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuji Heike

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 15, 2010
Phase 1 trial of Wilms tumor 1 (WT1) peptide vaccine and gemcitabine combination therapy in patients with advanced pancreatic or biliary tract cancerMiho Kaida, Yuriko Morita-Hoshi, Atsuko Soeda, et al.
International Journal of Cancer|April 6, 2006
Monitoring of WT1-specific cytotoxic T lymphocytes after allogeneic hematopoietic stem cell transplantationYuriko Morita, Yuji Heike, Mami Kawakami, et al.
International Journal of Hematology|May 8, 2007
Unrelated-donor bone marrow transplantation with a conditioning regimen including fludarabine, busulfan, and 4 Gy total body irradiationYasushi Onishi, Shin-ichiro Mori, Shigeru Kusumoto, et al.
Cancer Science|June 5, 2020
Expression of classical human leukocyte antigen class I antigens, HLA-E and HLA-G, is adversely prognostic in pancreatic cancer patientsNobuyoshi Hiraoka, Yoshinori Ino, Shutaro Hori, et al.
International Journal of Hematology|May 8, 2015
Infusion of donor lymphocytes expressing the herpes simplex virus thymidine kinase suicide gene for recurrent hematologic malignancies after allogeneic hematopoietic stem cell transplantationHisayoshi Hashimoto, Shigehisa Kitano, Ryosuke Ueda, et al.
Anticancer Research|May 4, 2005
Identification of serum proteins related to adverse effects induced by docetaxel infusion from protein expression profiles of serum using SELDI ProteinChip systemYuji Heike, Mami Hosokawa, Shozo Osumi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 23, 2008
Impact of T cell chimerism on clinical outcome in 117 patients who underwent allogeneic stem cell transplantation with a busulfan-containing reduced-intensity conditioning regimenBungo Saito, Takahiro Fukuda, Hiroki Yokoyama, et al.
European Journal of Haematology|October 17, 2013
Positive impact of chronic graft-versus-host disease on the outcome of patients with de novo myelodysplastic syndrome after allogeneic hematopoietic cell transplantation: a single-center analysis of 115 patientsNobuhiro Hiramoto, Saiko Kurosawa, Kinuko Tajima, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 21, 2007
Comparable antileukemia/lymphoma effects in nonremission patients undergoing allogeneic hematopoietic cell transplantation with a conventional cytoreductive or reduced-intensity regimenDai Maruyama, Takahiro Fukuda, Ruri Kato, et al.
International Journal of Hematology|September 13, 2015
Erratum to: Infusion of donor lymphocytes expressing the herpes simplex virus thymidine kinase suicide gene for recurrent hematologic malignancies after allogeneic hematopoietic stem cell transplantationHisayoshi Hashimoto, Shigehisa Kitano, Ryosuke Ueda, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 15, 2010
Phase 1 trial of Wilms tumor 1 (WT1) peptide vaccine and gemcitabine combination therapy in patients with advanced pancreatic or biliary tract cancerMiho Kaida, Yuriko Morita-Hoshi, Atsuko Soeda, et al.
International Journal of Cancer|April 6, 2006
Monitoring of WT1-specific cytotoxic T lymphocytes after allogeneic hematopoietic stem cell transplantationYuriko Morita, Yuji Heike, Mami Kawakami, et al.
International Journal of Hematology|May 8, 2007
Unrelated-donor bone marrow transplantation with a conditioning regimen including fludarabine, busulfan, and 4 Gy total body irradiationYasushi Onishi, Shin-ichiro Mori, Shigeru Kusumoto, et al.
Cancer Science|June 5, 2020
Expression of classical human leukocyte antigen class I antigens, HLA-E and HLA-G, is adversely prognostic in pancreatic cancer patientsNobuyoshi Hiraoka, Yoshinori Ino, Shutaro Hori, et al.
International Journal of Hematology|May 8, 2015
Infusion of donor lymphocytes expressing the herpes simplex virus thymidine kinase suicide gene for recurrent hematologic malignancies after allogeneic hematopoietic stem cell transplantationHisayoshi Hashimoto, Shigehisa Kitano, Ryosuke Ueda, et al.
Anticancer Research|May 4, 2005
Identification of serum proteins related to adverse effects induced by docetaxel infusion from protein expression profiles of serum using SELDI ProteinChip systemYuji Heike, Mami Hosokawa, Shozo Osumi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 23, 2008
Impact of T cell chimerism on clinical outcome in 117 patients who underwent allogeneic stem cell transplantation with a busulfan-containing reduced-intensity conditioning regimenBungo Saito, Takahiro Fukuda, Hiroki Yokoyama, et al.
European Journal of Haematology|October 17, 2013
Positive impact of chronic graft-versus-host disease on the outcome of patients with de novo myelodysplastic syndrome after allogeneic hematopoietic cell transplantation: a single-center analysis of 115 patientsNobuhiro Hiramoto, Saiko Kurosawa, Kinuko Tajima, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 21, 2007
Comparable antileukemia/lymphoma effects in nonremission patients undergoing allogeneic hematopoietic cell transplantation with a conventional cytoreductive or reduced-intensity regimenDai Maruyama, Takahiro Fukuda, Ruri Kato, et al.
International Journal of Hematology|September 13, 2015
Erratum to: Infusion of donor lymphocytes expressing the herpes simplex virus thymidine kinase suicide gene for recurrent hematologic malignancies after allogeneic hematopoietic stem cell transplantationHisayoshi Hashimoto, Shigehisa Kitano, Ryosuke Ueda, et al.
Pageof 8